Pandemic Timeline

Depositions

Dr. McCullough and Dr. Zelenko testify at Senate Homeland Security Committee hearing

Senator Ben Johnson (R-WI) is Chairman.

Dr. McCullough testifies of the importance of early treatment as a pillar of pandemic response.  He is one of the developers of the protocols on the  Frontline Covid-19 Critical Care Alliance site.

The second pillar is early ambulatory treatment. This virus infects individuals and they sit at home for two weeks. We have a two-week opportunity to treat this problem and we hear nothing about it. We hear nothing about early ambulatory treatment. There’s no updates. There’s no viewpoint to Americans of what’s going on outside of the United States where early ambulatory treatment is a standard of care in countries that are doing much better than the United States. It’s grossly overlooked….

With this pandemic and this virus what we’ve learned is that there’s an early viral replication phase followed by a destructive immune activation called cytokine storm and then blood clotting thrombosis.  What doctors have done is they’ve innovated and they’ve identified, both in the hospital and outside of the hospital, aided by clinical trials and observational studies, an approach that involves combination antivirals, followed by corticosteroids and antithrombotic agents. Doctors in the outpatient communities, faced with thousands of patients calling and begging for help, have innovated. Dr Zelenko is one in New York, in the middle of the calamity in New York, who was an early innovator.

— Dr. Peter McCullough

Dr. McCullough and other outpatient doctors, including Dr. Zelenko, prefer to treat patients early before the damaging cytokine storm and thrombosis begin.  Both doctors have developed protocols for prevention and treatment of COVID.

Note that the figure shows thrombosis and increased D-dimer.  This is a common adverse event found in the jabbed as well, according to Dr. Charles Hoffe.

Dr. Zelenko talked about the lobbying power of the pharmaceutical industry.  The “Pharmaceuticals/Health Products” industry spends about twice what any other industry spends on lobbying.  The chart also includes “Hospitals/Nursing Homes,” “Health Professionals,” and “Health Services/HMOs.”  These add up to 291.15, which is almost equal to “Pharmaceuticals/Health Products.”  All four combined is 586.32.  If the insurance industry had been separated into its various markets, the health insurance industry could have been added in as well.  Simply put, the medical industry wields huge lobbying power.

Lobbying chart as provided by Dr. Zelenko

Lobbying chart, archived from source Statista to better show detail

Dr. Zelenko then showed this evaluation Dr. Raoult’s study from France.  It appears that Dr. Zelenko felt challenged to show 0 on the graph, which was the result for hydroxychloroquine and azithromycin in the French study.  In other words, everyone treated with hydroxychloroquine and azithromycin survived.

In spite of testimonies like these, early treatment is are not part of the standard of care in the US.  Instead, early treatment options have been subjected to unwarranted vilification.  Meanwhile, other countries have been using early treatment protocols with great success.

One can only speculate about the motivation for ignoring the data about successful early treatments.  Either 1) they are so profit-motivated that they are ignoring what would be best for the people, or, worse, 2) some group of people really does want to kill off at least some portion of the population.  At least one deeply involved person has expressed eugenic desires.

Sources:

Related:

See also, on this site:

Comments are closed.